GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PAO Group Inc (OTCPK:PAOG) » Definitions » Risk Assessment

PAO Group (PAO Group) Risk Assessment


View and export this data going back to 2004. Start your Free Trial

What is PAO Group Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of PAO Group is: No Data: Cannot be evaluated.


Competitive Comparison of PAO Group's Risk Assessment

For the Medical Care Facilities subindustry, PAO Group's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PAO Group's Risk Assessment Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PAO Group's Risk Assessment distribution charts can be found below:

* The bar in red indicates where PAO Group's Risk Assessment falls into.



PAO Group  (OTCPK:PAOG) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


PAO Group Risk Assessment Related Terms

Thank you for viewing the detailed overview of PAO Group's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


PAO Group (PAO Group) Business Description

Traded in Other Exchanges
N/A
Address
11424 Frances Street, Suite B, Omaha, NE, USA, 68144
PAO Group Inc is a United States-based holding company. It seeks to develop, acquire, partner, or participate in, companies and concepts in the development and launch of alternative medicine clinics focused on non-traditional patient care solutions. The range of treatment solutions includes cannabis, acupuncture, chiropractic, biofeedback, and other solutions depending on patient needs. The group primarily operates in the United States of America.

PAO Group (PAO Group) Headlines

From GuruFocus

PAOG and PURA Announce Women's Health CBD Product Partnership

By PRNewswire PRNewswire 11-10-2021

PAOG Takes Next Step To Produce Cannabis Nutraceuticals

By PRNewswire PRNewswire 01-27-2021

PAOG Expects To Add CBD Nutraceuticals Revenue This Year

By PRNewswire PRNewswire 02-18-2021

PAOG Builds CBD "RX" Brand Now Introducing 2nd CBD Product

By PRNewswire PRNewswire 10-21-2021

PAOG To Build On CBD Business Through Acquisition

By PRNewswire PRNewswire 10-05-2021